| Author |
Year |
T(n) |
C(n) |
Cell type |
Cell dose (x100,000) |
Baseline EF |
Comparator arm |
outcome assessment |
surgical methods |
| Ang |
2008 |
21 |
21 |
unselected BMSC |
84 |
23.2 |
No sham injection |
MRI |
CABG |
| Hendrikx |
2006 |
10 |
10 |
unselected BMSC |
60 |
41.2 |
Heparinized saline |
MRI |
CABG |
| Hu |
2011 |
31 |
29 |
unselected BMSC |
131 |
23.7 |
patient own serum |
MRI |
CABG |
| Patel |
2005 |
10 |
10 |
selected BMSC |
22 |
30.1 |
No sham injection |
Echocardiography |
OPCAB |
| Stamm |
2007 |
22 |
21 |
selected BMSC |
5.8 |
37.7 |
No sham injection |
Echocardiography |
CABG |
| Yerebakan |
2011 |
20 |
20 |
selected BMSC |
7.2 |
40.8 |
No sham injection |
Echocardiography |
CABG |
| Zhao |
2008 |
18 |
18 |
unselected BMSC |
659 |
36.3 |
Heparinized saline |
Echocardiography |
CABG |
T (n): Number of Treatment Group Patients; C (n): Number of Control Group Patients; EF: Ejection Fraction; BMSC: Bone Marrow Stem Cell; CABG: Coronary Artery
Bypass Graft; MRI: Magnetic Resonance Imaging; OPCAB: Off-Pump Coronary Artery Bypass Grafting |
